Hospital Delivery Room versus Outdoor Birthing Place: Differences in Airborne Microorganisms and Their Impact on the Infant

Abstract

The incidence of allergic airway diseases continues to increase in industrial countries while remaining much more stable in developing countries. Allergens inhaled are eventually also swallowed and evidently the gastrointestinal immune system has a role in regulating allergic responses in the pulmonary as well as the GI system. While some studies have pointed out the role of probiotic bacteria as a supplementary protection against the early development of various allergies, little attention has been paid to the composition of the airborne microflora first and continuosly inhaled by newborns and infants. This study compares the composition of two airborne microbial communities, one from hospital delivery rooms and the other from a nature reserve, evidently in use as a birthing place as early as 7500 B.C. around the air from the outdoor birthing place was marked by a far greater variation in microbial composition and a much higher representation of fungi than the air from the hospitals. The dominant bacterial species from the delivery rooms were Staphylococcus areus and Micrococcus luteus, originating from the staff and the hospital environment; the outdoor flora, however, was dominated by Pseudomonas spp. and Bacillus spp. In addition, 56% of all the bacterial isolates from the delivery rooms were most closely related to strains previously associated with clinical infections, whereas only 15% of isolates in the outdoor bacterial sample had such relationships. The role of airborne microorganisms could be important to infants with developing immune systems considering the microbial bias of hospital air presented in this study.

Share and Cite:

T. Olofsson and A. Vàsquez, "Hospital Delivery Room versus Outdoor Birthing Place: Differences in Airborne Microorganisms and Their Impact on the Infant," Open Journal of Medical Microbiology, Vol. 3 No. 1, 2013, pp. 25-38. doi: 10.4236/ojmm.2013.31005.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] D. M. Mannino, D. M. Homa, C. A. Pertowski, A. Ashizawa, L. L. Nixon, C. A. Johnson, L. B. Ball, E. Jack and D. S. Kang, “Surveillance for Asthma—United States, 1960-1995,” MMWR CDC SurveillSumm, Vol. 47, No. 1, 1998, pp. 1-27.
[2] P. G. Burney, C. Luczynska, S. Chinn and D. Jarvis, “The European Community Respiratory Health Survey,” European Respiratory Journal, Vol. 7, No. 5, 1994, pp. 954960. doi:10.1183/09031936.94.07050954
[3] M. I. Asher, U. Keil, H. R. Anderson, R. Beasley, J. Crane, F. Martinez, E. A. Mitchell, N. Pearce, B. Sibbald, A. W. Stewart, et al., “International Study of Asthma and Allergies in Childhood (ISAAC): Rationale and Methods,” European Respiratory Journal, Vol. 8, No. 3, 1995, pp. 483-491. doi:10.1183/09031936.95.08030483
[4] R. Beasley, J. Crane, C. K. Lai and N. Pearce, “Prevalence and Etiology of Asthma,” Journal of Allergy and Clinical Immunology, Vol. 105, No. 2, 2000, pp. S466-S472.
[5] D. P. Strachan, “Hay Fever, Hygiene, and Household Size,” British Medical Journal, Vol. 299, No. 6710, 1989, pp. 1259-1260. doi:10.1136/bmj.299.6710.1259
[6] M. Wills-Karp, J. Santeliz and C. L. Karp, “The Germless Theory of Allergic Disease: Revisiting the Hygiene Hypothesis,” Nature Reviews Immunology, Vol. 1, No. 1, 2001, pp. 69-75. doi:10.1038/35095579
[7] D. T. Umetsu, J. J. McIntire, O. Akbari, C. Macaubas and R. H. DeKruyff, “Asthma: An Epidemic of Dysregulated Immunity,” Nature Immunology, Vol. 3, No. 8, 2002, pp. 715-720. doi:10.1038/ni0802-715
[8] G. Hall, C. G. Houghton, J. U. Rahbek, J. R. Lamb and E. R. Jarman, “Suppression of Allergen Reactive Th2 Mediated Responses and Pulmonary Eosinophilia by Intranasal Administration of an Immunodominant Peptide Is Linked to IL-10 Production,” Vaccine, Vol. 21, No. 5-6, 2003, pp. 549-561. doi:10.1016/S0264-410X(02)00394-8
[9] K. Takabayashi, L. Libet, D. Chisholm, J. Zubeldia and A. A. Horner, “Intranasal Immunotherapy Is More Effective than Intradermal Immunotherapy for the Induction of Airway Allergen Tolerance in Th2-Sensitized Mice,” Journal of Immunology, Vol. 170, No. 7, 2003, pp. 3898-3905.
[10] O. Akbari, P. Stock, R. H. DeKruyff and D. T. Umetsu, “Role of Regulatory T Cells in Allergy and Asthma,” Current Opinion in Immunology, Vol. 15, No. 6, 2003, pp. 627-633. doi:10.1016/j.coi.2003.09.012
[11] C. A. Herrick and K. Bottomly, “To Respond or Not to Respond: T cells in Allergic Asthma,” Nature Reviews Immunology, Vol. 3, No. 5, 2003, pp. 405-412. doi:10.1038/nri1084
[12] T. E. Pickett, M. F. Pasetti, J. E. Galen, M. B. Sztein and M. M. Levine, “In Vivo Characterization of the Murine Intranasal Model for Assessing the Immunogenicity of Attenuated Salmonella enterica Serovar Typhi Strains as Live Mucosal Vaccines and as Live Vectors,” Infection and Immunity, Vol. 68, No. 1, 2000, pp. 205-213. doi:10.1128/IAI.68.1.205-213.2000
[13] O. Alpan, “Oral Tolerance and Gut-Oriented Immune Response to Dietary Proteins,” Current Allergy and Asthma Reports, Vol. 1, No. 6, 2001, pp. 572-577. doi:10.1007/s11882-001-0067-6
[14] N. K. M. Smith, A. D. Eaton, L. M. Finlayson and P. Garside, “Oral Tolerance,” American Journal of Respiratory and Critical Care Medicine, Vol. 162, No. 4, 2000, pp. S175-S178.
[15] H. L. Weiner, “Oral Tolerance: Immune Mechanisms and the Generation of Th3-Type TGF-Beta-Secreting Regulatory Cells,” Microbes and Infection, Vol. 3, No. 11, 2001, pp. 947-954. doi:10.1016/S1286-4579(01)01456-3
[16] M. Russo, S. Jancar, A. L. Pereira de Siqueira, J. Mengel, E. Gomes, S. M. Ficker and A. M. Caetano de Faria, “Prevention of Lung Eosinophilic Inflammation by Oral Tolerance,” Immunology Letters, Vol. 61, No. 1, 1998, pp. 15-23. doi:10.1016/S0165-2478(97)00155-7
[17] M. Russo, M. A. Nahori, J. Lefort, E. Gomes, A. de Castro Keller, D. Rodriguez, O. G. Ribeiro, S. Adriouch, V. Gallois, A. M. de Faria and B. B. Vargaftig, “Suppression of Asthma-Like Responses in Different Mouse Strains by Oral Tolerance,” American Journal of Respiratory Cell and Molecular Biology, Vol. 24, No. 5, 2001, pp. 518-526.
[18] Y. Chung, J. Cho, Y. S. Chang, S. H. Cho and C. Y. Kang, “Preventive and Therapeutic Effects of Oral Tolerance in a Murine Model of Asthma,” Immunobiology, Vol. 206, No. 4, 2002, pp. 408-423. doi:10.1078/0171-2985-00190
[19] L. Dethlefsen, M. McFall-Ngai and D. A. Relman, “An Ecological and Evolutionary Perspective on Human-Microbe Mutualism and Disease,” Nature, Vol. 449, No. 7164, 2007, pp. 811-818. doi:10.1038/nature06245
[20] G. W. Tannock, “Normal Micro?ora: An Introduction to Microbes Inhabiting the Human Body,” Chapman & Hall, London, 1995.
[21] M. G. Dominguez-Bello, M. J. Blaser, R. E. Ley and R. Knight, “Development of the Human Gastrointestinal Microbiota and Insights from High-Throughput Sequencing,” Gastroenterology, Vol. 140, No. 6, 2011, pp. 1713-1719. doi:10.1053/j.gastro.2011.02.011
[22] P. L. Stark and A. Lee, “The Microbial Ecology of the Large Bowel of Breast-Fed and Formula-Fed Infants during the First Year of Life,” Journal of Medical Microbiology, Vol. 15, No. 2, 1982, pp. 189-203. doi:10.1099/00222615-15-2-189
[23] S. Fanaro, R. Chierici, P. Guerrini and V. Vigi, “Intestinal Microflora in Early Infancy: Composition and Development,” Acta Paediatrica Supplement, Vol. 91, No. 441, 2003, pp. 48-55.
[24] C. F. Favier, E. E. Vaughan, W. M. De Vos and A. D. Akkermans, “Molecular Monitoring of Succession of Bacterial Communities in Human Neonates,” Applied and Environmental Microbiology, Vol. 68, No. 1, 2002, pp. 219-226. doi:10.1128/AEM.68.1.219-226.2002
[25] R. I. Mackie, A. Sghir and H. R. Gaskins, “Developmental Microbial Ecology of the Neonatal Gastrointestinal Tract,” American Journal of Clinical Nutrition, Vol. 69, No. 5, 1999, pp. 1035S-1045S.
[26] B. Bjorksten, P. Naaber, E. Sepp and M. Mikelsaar, “The Intestinal Microflora in Allergic Estonian and Swedish 2-Year-Old Children,” Clinical & Experimental Allergy, Vol. 29, No. 3, 1999, pp. 342-346. doi:10.1046/j.1365-2222.1999.00560.x
[27] B. Bjorksten, E. Sepp, K. Julge, T. Voor and M. Mikelsaar, “Allergy Development and the Intestinal Microflora during the First Year of Life,” Journal of Allergy and Clinical Immunology, Vol. 108, No. 4, 2001, pp. 516-520. doi:10.1067/mai.2001.118130
[28] M. F. Bottcher, E. K. Nordin, A. Sandin, T. Midtvedt and B. Bjorksten, “Microflora-Associated Characteristics in Faeces from Allergic and Nonallergic Infants,” Clinical & Experimental Allergy, Vol. 30, No. 11, 2000, pp. 1590-1596. doi:10.1046/j.1365-2222.2000.00982.x
[29] M. Kalliomaki, P. Kirjavainen, E. Eerola, P. Kero, S. Salminen and E. Isolauri, “Distinct Patterns of Neonatal Gut Microflora in Infants in Whom Atopy Was and Was Not Developing,” Journal of Allergy and Clinical Immunology, Vol. 107, No. 1, 2001, pp. 129-134. doi:10.1067/mai.2001.111237
[30] P. V. Kirjavainen, E. Apostolou, T. Arvola, S. J. Salminen, G. R. Gibson and E. Isolauri, “Characterizing the Composition of Intestinal Microflora as a Prospective Treatment Target in Infant Allergic Disease,” FEMS Immunology & Medical Microbiology, Vol. 32, No. 1, 2001, pp. 1-7. doi:10.1111/j.1574-695X.2001.tb00526.x
[31] P. V. Kirjavainen, T. Arvola, S. J. Salminen and E. Isolauri, “Aberrant Composition of Gut Microbiota of Allergic Infants: A Target of Bifidobacterial Therapy at Weaning?” Gut, Vol. 51, No. 1, 2002, pp. 51-55. doi:10.1136/gut.51.1.51
[32] I. M. Maurer, “Hospital Hygiene,” Wright PSG, Bristol, 1985.
[33] B. J. Collins, “The Hospital Environment: How Clean Should a Hospital Be?” Journal of Hospital Infection, Vol. 11, No. A, 1988, pp. 53-56.
[34] H. Gaze, “Dirt in Hospitals. Sweeping Change?” Nursing Times, Vol. 86, No. 24, 1990, pp. 27-28.
[35] M. Thomson and P. Hempshall, “Dirt Alert,” Nursing Times, Vol. 94, No. 28, 1998, pp. 63-64.
[36] R. Fekety, K. H. Kim, D. Brown, D. H. Batts, M. Cudmore and J. Silva Jr., “Epidemiology of Antibiotic-Associated Colitis; Isolation of Clostridium Difficile from the Hospital Environment,” The American Journal of Medicine, Vol. 70, No. 4, 1981, pp. 906-908. doi:10.1016/0002-9343(81)90553-2
[37] W. A. Rutala, M. F. Gergen and D. J. Weber, “Inactivation of Clostridium Difficile Spores by Disinfectants,” Infection Control and Hospital Epidemiology, Vol. 14, No. 1, 1993, pp. 36-39. doi:10.1086/646628
[38] B. R. Birch, B. S. Perera, W. A. Hyde, V. Ruehorn, L. A. Ganguli, J. M. Kramer and P. C. Turnbull, “Bacillus Cereus Cross-Infection in a Maternity-Unit,” Journal of Hospital Infection, Vol. 2, No. 4, 1981, pp. 349-354. doi:10.1016/0195-6701(81)90067-0
[39] D. Barrie, P. N. Hoffman, J. A. Wilson and J. M. Kramer, “Contamination of Hospital Linen by Bacillus cereus,” Epidemiology and Infection, Vol. 113, No. 2, 1994, pp. 297-306. doi:10.1017/S0950268800051724
[40] H. M. Aucken, M. E. Kaufmann and T. L. Pitt., “The Spread of Multi-Resistent Epidemic Klebsiella Strain in London and beyond,” 4th International Conference of the Hospital Infection Society, Edinburgh International Conference Centre, 1998.
[41] M. W. Casewell, J. E. Cooper and M. Webster, “Enteral Feeds Contaminated with Enterobacter cloacae as a Cause of Septicaemia,” British Medical Journal, Vol. 282, No. 6268, 1981, p. 973. doi:10.1136/bmj.282.6268.973
[42] A. A. Forder, “Buckets and Mops in Operating-Theatres,” Lancet, Vol. 1, No. 7815, 1973, p. 1325. doi:10.1016/S0140-6736(73)91349-4
[43] J. L. Whitby, J. N. Blair and A. Rampling, “Cross-Infection with Serratia marcescens in an Intensive-Therapy Unit,” Lancet, Vol. 2, No. 7768, 1972, pp. 127-129. doi:10.1016/S0140-6736(72)91612-1
[44] S. Heard, S. Lawrence, B. Holmes and M. Costas, “A Pseudo-Outbreak of Pseudomonas on a Special Care Baby Unit,” Journal of Hospital Infection, Vol. 16, No. 1, 1990, pp. 59-65. doi:10.1016/0195-6701(90)90049-T
[45] E. K. Musa, N. Desai and M. W. Casewell, “The Survival of Acinetobacter calcoaceticus Inoculated on Fingertips and on Formica,” Journal of Hospital Infection, Vol. 15, No. 3, 1990, pp. 219-227. doi:10.1016/0195-6701(90)90029-N
[46] P. Pina, P. Guezenec, S. Grosbuis, L. Guyot, J. C. Ghnassia and P. Y. Allouch, “An Acinetobacter baumanii Outbreak at the Versailles Hospital Center,” Biology and Pathology (Paris), Vol. 46, No. 6, 1998, pp. 385-394.
[47] R. A. Cox, C. Conquest, C. Mallaghan and R. R. Marples, “A Major Outbreak of Methicillin-Resistant Staphylococcus aureus Caused by a New Phage-Type (EMRSA16),” Journal of Hospital Infection, Vol. 29, No. 2, 1995, pp. 87-106. doi:10.1016/0195-6701(95)90191-4
[48] T. R. Frieden, S. S. Munsiff, D. E. Low, B. M. Willey, G. Williams, Y. Faur, W. Eisner, S. Warren and B. Kreiswirth, “Emergence of Vancomycin-Resistant Enterococci in New York City,” Lancet, Vol. 342, No. 8863, 1993, pp. 76-79. doi:10.1016/0140-6736(93)91285-T
[49] L. A. Mermel, S. L. Josephson, C. H. Giorgio, J. Dempsey and S. Parenteau, “Association of Legionnaires’ Disease with Construction: Contamination of Potable Water?” Infection Control and Hospital Epidemiology, Vol. 16, No. 2, 1995, pp. 76-81. doi:10.1086/647060
[50] V. G. Loo, C. Bertrand, C. Dixon, D. Vitye, B. DeSalis, A. P. McLean, A. Brox and H. G. Robson, “Control of Construction-Associated Nosocomial Aspergillosis in an Antiquated Hematology Unit,” Infection Control and Hospital Epidemiology, Vol. 17, No. 6, 1996, pp. 360-364. doi:10.1086/647317
[51] A. E. Aiello, J. Cimiotti, P. Della-Latta and E. L. Larson, “A Comparison of the Bacteria Found on the Hands of ‘Homemakers’ and Neonatal Intensive Care Unit Nurses,” Journal of Hospital Infection, Vol. 54, No. 4, 2003, pp. 310-315. doi:10.1016/S0195-6701(03)00146-4
[52] A. Al Maghlouth, Y. Al Yousef and N. Al Bagieh, “Qualitative and Quantitative Analysis of Bacterial Aerosols,” Journal of Contemporary Dental Practice, Vol. 5, No. 4, 2004, pp. 91-100.
[53] T. Nilsson. “Fr?n Istid till Bads?ssong,” 2003. http://www.skane-online.se/kullaberg/franis.htm
[54] J. Brosius, M. L. Palmer, P. J. Kennedy and H. F. Noller, “Complete Nucleotide Sequence of a 16S Ribosomal RNA gene from Escherichia coli,” Proceedings of the National Academy of Sciences of USA, Vol. 75, No. 10, 1978, pp. 4801-4805.doi:10.1073/pnas.75.10.4801
[55] S. F. Altschul, T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller and D. J. Lipman, “Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs,” Nucleic Acids Research, Vol. 25, No. 17, 1997, pp. 3389-3402. doi:10.1093/nar/25.17.3389
[56] J. R. Cole, B. Chai, R. J. Farris, Q. Wang, S. A. Kulam, D. M. McGarrell, G. M. Garrity and J. M. Tiedje, “The Ribosomal Database Project (RDP-II): Sequences and Tools for High-Throughput rRNA Analysis,” Nucleic Acids Research, Vol. 33, 2005, pp. D294-D296.
[57] L. P?hlsson, “The Trees That Bear Witness to Ancient Times,” Helsingborg Daily, Helsingborg, 2003.
[58] J. Kraft, “Inventory of Plant Flora in Brunnby Parish with Kullaberg,” The Botanical Society of Lund, Lund, 1982.
[59] J. Keswani and W. B. Whitman, “Relationship of 16S rRNA Sequence Similarity to DNA Hybridization in Prokaryotes,” International Journal of Systematic and Evolutionary Microbiology, Vol. 51, No. 2, 2001, pp. 667-678.
[60] A. Suau, R. Bonnet, M. Sutren, J. J. Godon, G. R. Gibson, M. D. Collins and J. Dore, “Direct Analysis of Genes Encoding 16S rRNA from Complex Communities Reveals Many Novel Molecular Species within the Human Gut,” Applied and Environmental Microbiology, Vol. 65, No. 11, 1999, pp. 4799-4807.
[61] I. Kroes, P. W. Lepp and D. A. Relman, “Bacterial Diversity within the Human Subgingival Crevice,” Proceedings of the National Academy of Sciences of USA, Vol. 96, No. 25, 1999, pp. 14547-14552. doi:10.1073/pnas.96.25.14547
[62] K. Y. Kim, Y. S. Kim and D. Kim, “Distribution Characteristics of Airborne Bacteria and Fungi in the General Hospitals of Korea,” Industrial Health, Vol. 48, No. 2, 2010, pp. 236-243. doi:10.2486/indhealth.48.236
[63] M. Kalliomaki, S. Salminen, H. Arvilommi, P. Kero, P. Koskinen and E. Isolauri, “Probiotics in Primary Prevention of atopic Disease: A Randomised Placebo-Controlled Trial,” Lancet, Vol. 357, No. 9262, 2001, pp. 1076-1079. doi:10.1016/S0140-6736(00)04259-8
[64] M. Kalliomaki, S. Salminen, T. Poussa, H. Arvilommi and E. Isolauri, “Probiotics and Prevention of Atopic Disease: 4-Year Follow-Up of a Randomised Placebo-Controlled Trial,” Lancet, Vol. 361, No. 9372, 2003, pp. 1869-1871. doi:10.1016/S0140-6736(03)13490-3
[65] H. Majamaa and E. Isolauri, “Probiotics: A Novel Approach in the Management of Food Allergy,” Journal of Allergy and Clinical Immunology, Vol. 99, No. 2, 1997, pp. 179-185. doi:10.1016/S0091-6749(97)70093-9
[66] E. Isolauri, T. Arvola, Y. Sutas, E. Moilanen and S. Salminen, “Probiotics in the Management of Atopic Eczema,” Clinical & Experimental Allergy, Vol. 30, No. 11, 2000, pp. 1604-1610. doi:10.1046/j.1365-2222.2000.00943.x
[67] K. Laiho, U. Hoppu, A. C. Ouwehand, S. Salminen and E. Isolauri, “Probiotics: On-Going Research on Atopic Individuals,” British Journal of Nutrition, Vol. 88, No. 1, 2002, pp. S19-S27. doi:10.1079/BJN2002626
[68] V. Rosenfeldt, E. Benfeldt, S. D. Nielsen, K. F. Michaelsen, D. L. Jeppesen, N. H. Valerius and A. Paerregaard, “Effect of Probiotic Lactobacillus Strains in Children with Atopic Dermatitis,” Journal of Allergy and Clinical Immunology, Vol. 111, No. 2, 2003, pp. 389-395. doi:10.1067/mai.2003.389
[69] M. Viljanen, E. Savilahti, T. Haahtela, K. JuntunenBackman, R. Korpela, T. Poussa, T. Tuure and M. Kuitunen, “Probiotics in the Treatment of Atopic Eczema/ Dermatitis Syndrome in Infants: A Double-Blind PlaceboControlled Trial,” Allergy, Vol. 60, No. 4, 2005, pp. 494-500. doi:10.1111/j.1398-9995.2004.00514.x
[70] R. Lodinova-Zadnikova, B. Cukrowska and H. Tlaskalova-Hogenova, “Oral Administration of Probiotic Escherichia coli after Birth Reduces Frequency of Allergies and Repeated Infections Later in Life (after 10 and 20 Years),” International Archives of Allergy and Immunology, Vol. 131, No. 3, 2003, pp. 209-211. doi:10.1159/000071488
[71] A. Jain, J. Agarwal and S. Bansal, “Prevalence of Methicillin-Resistant, Coagulase-Negative Staphylococci in Neonatal Intensive Care Units: Findings from a Tertiary Care Hospital in India,” Journal of Medical Microbiology, Vol. 53, No. 9, 2004, pp. 941-944.
[72] P. C. Ng, V. C. Chow, C. H. Lee, J. M. Ling, H. L. Wong and R. C. Chan, “Persistent Staphylococcus Capitis Septicemia in a Preterm Infant,” The Pediatric Infectious Disease Journal, Vol. 25, No. 7, 2006, pp. 652-654. doi:10.1097/01.inf.0000225785.32137.d3
[73] V. Milisavljevic, F. Wu, J. Cimmotti, J. Haas, P. DellaLatta, E. Larson and L. Saiman, “Genetic Relatedness of Staphylococcus Epidermidis from Infected Infants and Staff in the Neonatal Intensive Care Unit,” Am J Infect Control, Vol. 33, No. 6, 2005, pp. 341-347. doi:10.1016/j.ajic.2005.02.003
[74] C. von Eiff, N. Kuhn, M. Herrmann, S. Weber and G. Peters, “Micrococcus luteus as a Cause of Recurrent Bacteremia,” American Journal of Infection Control, Vol. 15, No. 8, 1996, pp. 711-713. doi:10.1097/00006454-199608000-00019
[75] H. Seifert, A. Strate, A. Schulze and G. Pulverer, “Vascular Catheter-Related Bloodstream Infection Due to Acinetobacter johnsonii (Formerly Acinetobacter calcoaceticus var. lwoffi): Report of 13 Cases,” Clinical Infectious Diseases, Vol. 17, No. 4, 1993, pp. 632-636. doi:10.1093/clinids/17.4.632
[76] M. Dalamaga, K. Karmaniolas, C. Chavelas, S. Liatis, H. Matekovits and I. Migdalis, “Pseudomonas luteola Cutaneous Abscess and Bacteraemia in a Previously Healthy Man,” Scandinavian Journal of Infectious Diseases, Vol. 36, No. 6-7, 2004, pp. 495-497. doi:10.1080/00365540310016196
[77] A. Kumar, J. Sandoe and N. Kumar, “Three Cases of Vertebral Osteomyelitis Caused by Streptococcus dysgalactiae subsp. Equisimilis,” Journal of Medical Microbiology, Vol. 54, No. 11, 2005, pp. 1103-1105.
[78] K. Ahmed, K. Kawakami, K. Watanabe, H. Mitsushima, T. Nagatake and K. Matsumoto, “Corynebacterium pseudodiphtheriticum: A Respiratory Tract Pathogen,” Clinical Infectious Diseases, Vol. 20, No. 1, 1995, pp. 41-46. doi:10.1093/clinids/20.1.41
[79] C. Ohuabunwo, J. Perevoscikovs, A. Griskevica, P. Gargiullo, A. Brilla, L. Viksna, S. Glismann, M. Wharton and C. Vitek, “Respiratory Diphtheria among Highly Vaccinated Military Trainees in Latvia: Improved Protection from DT Compared with Td Booster Vaccination,” Scandinavian Journal of Infectious Diseases, Vol. 37, No. 11-12, 2005, pp. 813-820. doi:10.1080/00365540500262658
[80] I. Mohammedi, C. Berchiche, K. Becker, K. Belkhouja, D. Robert, C. von Eiff and J. Etienne, “Fatal Kytococcusschroeteribacteremic pneumonia,” Journal of Infection, Vol. 51, No. 2, 2005, pp. E11-E13. doi:10.1016/j.jinf.2004.06.013
[81] P. Kampfer, S. Engelhart, M. Rolke and J. Sennekamp, “Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) Caused by Sphingobacterium spiritivorum from the Water Reservoir of a Steam Iron,” Journal of Clinical Microbiology, Vol. 43, No. 9, 2005, pp. 4908-4910. doi:10.1128/JCM.43.9.4908-4910.2005
[82] C. Palmer, E. M. Bik, D. B. DiGiulio, D. A. Relman and P. O. Brown, “Development of the Human Infant Intestinal Microbiota,” PLoS Biology, Vol. 5, No. 7, 2007, p. e177. doi:10.1371/journal.pbio.0050177
[83] R. E. Ley, M. Hamady, C. Lozupone, P. J. Turnbaugh, R. R. Ramey, J. S. Bircher, M. L. Schlegel, T. A. Tucker, M. D. Schrenzel, R. Knight and J. I. Gordon, “Evolution of Mammals and Their Gut Microbes,” Science, Vol. 320, No. 5883, 2008, pp. 1647-1651. doi:10.1126/science.1155725
[84] J. Walter and R. Ley, “The Human Gut Microbiome: Ecology and Recent Evolutionary Changes,” Annual Review of Microbiology, Vol. 65, 2011, pp. 411-429. doi:10.1146/annurev-micro-090110-102830
[85] E. Castagnola, F. Fioredda, M. A. Barretta, L. Pescetto, A. Garaventa, E. Lanino, C. Micalizzi, R. Giacchino and G. Dini, “Bacillus sphaericusbacteraemia in Children with Cancer: Case Reports and Literature Review,” Journal of Hospital Infection, Vol. 48, No. 2, 2001, pp. 142-145. doi:10.1053/jhin.2001.0995
[86] O. H. Cuello, M. J. Caorlin, V. E. Reviglio, L. Carvajal, C. P. Juarez, E. Palacio de Guerra and J. D. Luna, “Rhodococcusgloberulus keratitis after Laser in Situ Keratomileusis,” Journal of Cataract & Refractive Surgery, Vol. 28, No. 12, 2002, pp. 2235-2237. doi:10.1016/S0886-3350(01)01347-5
[87] J. Milanowski, J. Dutkiewicz, H. Potoczna, L. Kus and B. Urbanowicz, “Allergic Alveolitis among Agricultural Workers in Eastern Poland: A Study of Twenty Cases,” Annals of Agricultural and Environmental Medicine, Vol. 5, No. 1, 1998, pp. 31-43.
[88] F. Altuntas, O. Yildiz, B. Eser, K. Gundogan, B. Sumerkan and M. Cetin, “Catheter-Related Bacteremia Due to Kocuriarosea in a Patient Undergoing Peripheral Blood Stem Cell Transplantation,” BMC Infectious Diseases, Vol. 4, No. 1, 2004, p. 62. doi:10.1186/1471-2334-4-62
[89] P. Bemer-Melchior, A. Haloun, P. Riegel and H. B. Drugeon, “Bacteremia Due to Dietziamaris in an Immunocompromised Patient,” Clinical Infectious Diseases, Vol. 29, No. 5, 1999, pp. 1338-1340. doi:10.1086/313490
[90] H. Levenga, P. Donnelly, N. Blijlevens, P. Verweij, H. Shirango and B. de Pauw, “Fatal Hemorrhagic Pneumonia Caused by Infection Due to Kytococcus sedentarius— A Pathogen or Passenger?” Annals of Hematology, Vol. 83, No. 7, 2004, pp. 447-449. doi:10.1007/s00277-003-0831-x
[91] C. G. Loftus, G. C. Harewood, F. R. Cockerill and J. A. Murray, “Clinical Features of Patients with Novel Yersinia Species,” Digestive Diseases and Sciences, Vol. 47, No. 12, 2002, pp. 2805-2810. doi:10.1023/A:1021081911456
[92] B. La Scola, R. J. Birtles, M. N. Mallet and D. Raoult, “Massiliatimonae gen. nov., sp. nov., Isolated from Blood of an Immunocompromised Patient with Cerebellar Lesions,” Journal of Clinical Microbiology, Vol. 36, No. 10, 1998, pp. 2847-2852.
[93] X. Y. Han and R. A. Andrade, “Brevundimonas diminuta Infections and Its Resistance to Fluoroquinolones,” Journal of Antimicrobial Chemotherapy, Vol. 55, No. 6, 2005, pp. 853-859. doi:10.1093/jac/dki139
[94] W. E. Kloos, C. G. George, J. S. Olgiate, L. Van Pelt, M. L. McKinnon, B. L. Zimmer, E. Muller, M. P. Weinstein and S. Mirrett, “Staphylococcus hominis subsp. novobiosepticus subsp. nov., a Novel Trehaloseand N-AcetylD-Glucosamine-Negative, Novobiocinand MultipleAntibiotic-Resistant Subspecies Isolated from Human Blood Cultures,” International Journal of Systematic and Evolutionary Microbiology, Vol. 48, No. 3, 1998, pp. 799-812. doi:10.1099/00207713-48-3-799
[95] R. Raz, R. Colodner and C. M. Kunin, “Who Are You— Staphylococcus saprophyticus?” Clinical Infectious Diseases, Vol. 40, No. 6, 2005, pp. 896-898. doi:10.1086/428353
[96] S. M. Wang, C. C. Liu, H. W. Tseng, Y. J. Yang, C. H. Lin, A. H. Huang and Y. H. Wu, “Staphylococcus capitis Bacteremia of Very Low Birth Weight Premature Infants at Neonatal Intensive Care Units: Clinical Significance and Antimicrobial Susceptibility,” Journal of Microbiology, Immunology and Infection, Vol. 32, No. 1, 1999, pp. 26-32.
[97] O. Chesneau, A. Morvan, F. Grimont, H. Labischinski and N. el Solh, “Staphylococcus pasteuri sp. nov., Isolated from Human, Animal, and Food Specimens,” International Journal of Systematic and Evolutionary Microbiology, Vol. 43, No. 2, 1993, pp. 237-244. doi:10.1099/00207713-43-2-237
[98] N. Announ, J. P. Mattei, S. Jaoua, F. Fenollar, H. Sati, C. Chagnaud, J. Roudier and S. Guis, “Multifocal Discitis Caused by Staphylococcus warneri,” Joint Bone Spine, Vol. 71, No. 3, 2004, pp. 240-242. doi:10.1016/S1297-319X(03)00126-X
[99] M. Alvarez Posadilla, P. Linares Torres, C. Bailador Andres, P. Suarez Alvarez and J. L. OlcozGoni, “Bacteriemia Caused by Staphylococcus cohnii Associated with Acute Cholecystitis,” Annals of Internal Medicine, Vol. 23, No. 1, 2006, pp. 51-52.
[100] H. Seifert, R. Baginski, A. Schulze and G. Pulverer, “The Distribution of Acinetobacter Species in Clinical Culture Materials,” Zentralblatt für Bakteriologie, Vol. 279, No. 4, 1993, pp. 544-552. doi:10.1016/S0934-8840(11)80427-5
[101] A. Jawad, A. M. Snelling, J. Heritage and P. M. Hawkey, “Exceptional Desiccation Tolerance of Acinetobacter radioresistens,” Journal of Hospital Infection, Vol. 39, No. 3, 1998, pp. 235-240. doi:10.1016/S0195-6701(98)90263-8
[102] K. Laffineur, V. Avesani, G. Cornu, J. Charlier, M. Janssens, G. Wauters and M. Delmee, “Bacteremia Due to a Novel Microbacterium Species in a Patient with Leukemia and Description of Microbacteriumparaoxydans sp. nov,” Journal of Clinical Microbiology, Vol. 41, No. 5, 2003, pp. 2242-2246. doi:10.1128/JCM.41.5.2242-2246.2003
[103] S. G. Jackson, R. B. Goodbrand, R. Ahmed and S. Kasatiya, “Bacillus cereus and Bacillus thuringiensis Isolated in a Gastroenteritis Outbreak Investigation,” Letters in Applied Microbiology, Vol. 21, No. 2, 1995, pp. 103-105. doi:10.1111/j.1472-765X.1995.tb01017.x
[104] J. P. Casalta, P. E. Fournier, G. Habib, A. Riberi and D. Raoult, “Prosthetic Valve Endocarditis Caused by Pseudomonas luteola,” BMC Infectious Disease, Vol. 5, 2005, p. 82. doi:10.1186/1471-2334-5-82

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.